Repare Therapeutics Inc. (RPTX) Tops Q2 EPS by 5c

Repare Therapeutics Inc. (NASDAQ: RPTX) reported Q2 EPS of ($0.82), $0.05 better than the analyst estimate of ($0.87). Revenue for the quarter came in at $1.07 million versus the consensus estimate of $2.58 million.

For earnings history and earnings-related data on Repare Therapeutics Inc. (RPTX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Can Anthropic actually match or beat SpaceX’s IPO? Numbers say "Yes, but"
• Westlake Corp adds dual listing on NYSE Texas exchange